Texas Instruments stock steadies after-hours as $7 billion Silicon Laboratories talks report surfaces

Texas Instruments stock steadies after-hours as $7 billion Silicon Laboratories talks report surfaces

New York, Feb 3, 2026, 18:26 EST — After-hours

Texas Instruments (TXN.O) held steady near $225 in after-hours on Tuesday after the Financial Times reported it’s nearing a $7 billion deal to buy Silicon Laboratories. Silicon Labs surged 28%, while Texas Instruments dipped about 1% in extended trading; Reuters has not been able to confirm the story. The stock closed up a fraction, rising 0.13% to $225.21. (Reuters)

The buzz matters since a deal that large would stand as one of TI’s biggest moves, potentially reshaping investor views on its capital spending. The last time TI pulled off a mega-deal was back in 2011, when it paid about $6.5 billion in cash to acquire National Semiconductor. (Texas Instruments)

The timing couldn’t be worse. The Nasdaq Composite dropped 1.43%, while the S&P 500 slipped 0.84%, as investors grew cautious that emerging AI tools might tighten margins in software and services. “Many areas, especially around AI, are priced for perfection,” noted John Campbell from Allspring Global Investments. Art Hogan, chief market strategist at B. Riley Wealth, added, “We’re seeing a lot of software companies across the spectrum get hit.” (Reuters)

Silicon Labs makes wireless chips and modules that link devices using Bluetooth, Wi‑Fi, and other protocols. The company holds a strong position in the Internet of Things market—a broad category covering everything from smart-home gadgets to industrial sensors. (Silicon Labs)

Texas Instruments develops and manufactures analog and embedded processing chips for industrial and automotive sectors, along with applications in data centers, personal electronics, and communications equipment, the firm states. (Texas Instruments)

During regular trading, TI managed a slight gain, unlike its chip industry peers. NXP Semiconductors dropped 4.51%, and Analog Devices declined 1.76%, according to MarketWatch data. (MarketWatch)

Deal talks can still collapse without a handshake. And if a deal does get done, investors will scrutinize the price, potential regulatory hurdles, and whether TI can integrate a wireless-focused unit without losing sight of its core customers.

Next on the radar: traders will look for confirmation, denial, or any filings over the next few days, plus how TXN kicks off Wednesday’s session. TI plans a capital management webcast on Feb. 24 at 10 a.m. Central time. (Texas Instruments)

Stock Market Today

  • Novo Nordisk Shares Drop 14.75% on Weaker 2026 Outlook Amid Obesity-Drug Market Pressure
    February 3, 2026, 8:15 PM EST. Novo Nordisk shares plunged 14.75% to $50.33 after management projected a 2026 sales and profit decline, despite recent strong results. The Danish drugmaker faces pricing pressure and rising competition in obesity treatments, particularly in the U.S. Trading volume surged to 67.7 million shares, nearly triple the average. The company forecasts a 5%-13% sales drop in 2026, driven by price cuts, patent expirations, and intensified rivalry. Meanwhile, pharma peers Eli Lilly and Novartis also closed lower amid broader sector weakness. Investors will monitor Novo Nordisk's strategy expansion and new therapies like the Wegovy pill as key to restoring growth momentum.
Netflix stock price slides as Warner Bros deal scrutiny tightens
Previous Story

Netflix stock price slides as Warner Bros deal scrutiny tightens

JPMorgan stock jumps while Wall Street slides — why JPM shares held up and what’s next
Next Story

JPMorgan stock jumps while Wall Street slides — why JPM shares held up and what’s next

Go toTop